Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines-Reference-Cited by-同舟云学术

Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines

Published:2018 Issue:2 Volume:47 Page:517-527
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Mandal Poulami¹²³⁴⁵^ORCID,Kundu Bidyut Kumar¹²³⁴⁵,Vyas Komal¹²³⁴⁵,Sabu Vidya⁶⁷⁸⁵,Helen A.⁶⁷⁸⁵,Dhankhar Sandeep Singh¹⁹¹⁰⁵,Nagaraja C. M.¹⁹¹⁰⁵^ORCID,Bhattacherjee Debojit¹¹¹¹²⁵,Bhabak Krishna Pada¹¹¹¹²⁵,Mukhopadhyay Suman¹²³⁴⁵^ORCID

Affiliation:

1. Department of Chemistry

2. School of Basic Sciences

3. Indian Institute of Technology Indore

4. Indore 453552

5. India

6. Department of Biochemistry

7. University of Kerala

8. Kariavattom campus

9. Indian Institute of Technology Ropar

10. Rupnagar 140001

11. Indian Institute of Technology Guwahati

12. Guwahati 781039

Abstract

Ru(ii)–arene complexes with NSAIDs as co-ligands show marked antiproliferative activity against cancer cell lines along with cyclooxygenase inhibition properties.

Funder

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/DT/C7DT03637J

Reference62 articles.

1. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

2. Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs

3. 100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs

4. Metal-based drugs that break the rules

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bovine serum albumin uptake and polypeptide disaggregation studies of hypoglycemic ruthenium(II) uracil Schiff-base complexes;Journal of Inorganic Biochemistry;2024-06

2. Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents;Drug Development Research;2024-02-14

3. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024

4. Synthesis, structure and biological activity of silver(I) complexes containing triphenylphosphine and non-steroidal anti-inflammatory drug ligands;Journal of Inorganic Biochemistry;2024-01

5. Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy;Coordination Chemistry Reviews;2024-01